Brieflands

History

The company was first founded by Seyyed M. Miri and Seyed-M Alavian as an editorial group in a Medical Institute in 2007 to publish its medical journal. After three years of experience, the number of journals increased to 5 journals, and the company launched its first form of business as a VOF (collaboration) professional STM company in Heerlen, the Netherlands, which was called "Kowsarmedical Publishing." Respecting the publishing services (from submission to publishing), especially an in-house "Journal Management System," our journals increased to more than 60 STM journals between 2010 and 2019. Since 2022, "Brieflands" is the new brand name that acts as a "Science, Technical, Medical Publisher" that publishes more than 50 journals with the services provided by 97 expert employees in three different branches.

Business Profile

  • Brieflands is a Registered Trademark with record number 1454012.
  • Brieflands has been registered as a General partnership (Vennootschap onder firma) company in the Chamber of Commerce (Kamer van Koophandel) of the Netherlands since 2010.
  • Nedmedica is our related company which is specialized in Author Services. 
  • Our former branding name was Kowsarmedical Publishing (2010-2021).
 

Communities in Brieflands Repository

Select a community to browse its collections

Recent Submissions

Thumbnail Image
Item
Dexmedetomidine Nasal Packing Versus Intravenous Dexmedetomidine for Controlling Bleeding During Turbinate Surgeries: A Randomized Double-Blind Trial
(Brieflands, 2024-11-19) Wafaa Mohamed Abdelsalam; Adel Ali Hassan; Basma Ghoniem; Mahmoud Fawzy Elsharkawy; Gamal Hendawy Shams
Background: Nasal obstruction due to hypertrophied turbinates (HT) is one of the common reasons for patients undergoing turbinate operations. This condition is associated with intraoperative nasal bleeding, which can obscure visibility of the field and prolong surgery time. Objectives: The purpose of this study is to compare dexmedetomidine-soaked nasal packing (NP) and intravenous (IV) dexmedetomidine (DEX) for managing bleeding during turbinate surgeries to reduce blood loss and improve surgical field quality. Methods: This randomized, double-blind trial was conducted on 60 patients aged between 18 and 65 years undergoing turbinate surgeries. Patients were randomly assigned into two equal groups: Group NP received DEX-soaked NP (1.5 µg/kg for 10 minutes) and an IV saline bolus followed by saline infusion. Group IV received a 0.5 µg/kg DEX bolus over 10 minutes, followed by a 0.1 - 0.4 µg/kg per hour IV infusion and saline-soaked NP. Results: The mean intraoperative blood loss was 124.1 ± 34.85 mL in group NP and 115.63 ± 31.89 mL in group IV, with no significant difference. Intraoperative hemodynamics, surgical field quality scores, time to first rescue analgesia, total postoperative pethidine consumption, pain score, patient satisfaction, and side effects were comparable. Conclusions: Dexmedetomidine NP is non-inferior to IV DEX for controlling intraoperative bleeding during turbinate surgery. Both methods provided comparable surgical field quality, patient satisfaction, and pain management outcomes.
Thumbnail Image
Item
Comparison of Different Concentrations of Antibiotics with Nanoparticles Synthesized by Biological Method on Pseudomonas aeruginosa Isolated from The Surface
(Brieflands, 2025-01-31) Fatemeh Mahmoodi; Tahereh Eslam-Manesh; Somayeh Sargolzaei; Afsaneh Mirshekari; Mehdi Jahantigh
Background: The widespread and indiscriminate use of antibiotics, disinfectants, and antiseptics in medical centers has led to the emergence of resistance in Pseudomonas aeruginosa, a major cause of hospital infections. Objectives: This study aims to compare the effects of antibiotics—cotrimoxazole, cephalexin, cefotaxime, cefazolin, gentamicin, imipenem, ampicillin, and ceftazidime—with silver nanoparticles synthesized in medicinal plant extract against Pseudomonas aeruginosa bacteria. Methods: Ten antibiotic-resistant strains of Pseudomonas aeruginosa were isolated from surfaces at the maternity hospital of Amir al-Mominin Hospital in Zabul city. In this study, nanoparticles were synthesized using an aqueous extract of the medicinal plant Capparis. The minimum inhibitory concentration (MIC) and minimum lethal concentration (MLC) of the synthesized nanoparticles and antibiotics were determined by the microdilution method. Results: The minimum inhibitory concentrations for the antibiotics ceftriaxone, cephalexin, cotrimoxazole, gentamicin, cefotaxime, imipenem, ceftazidime, ampicillin, and cefazolin were 128, 64, 32, 16, 4, 64, 64, 8, and 64 µg/mL, respectively. The minimum inhibitory concentration for the synthesized silver nanoparticles was 1024 μg/mL, with inhibition observed in four strains at this concentration. Conclusions: This study demonstrated good antimicrobial effects of synthesized silver nanoparticles on Pseudomonas aeruginosa. Therefore, silver nanoparticles may be recommended as a potent antimicrobial agent for disinfecting hospital surfaces.
Thumbnail Image
Item
Study the Effect of Dry Needling of Leg Muscles on Ankle Joint Position Sense and Functional Disability in Patients with Chronic Ankle Sprain: A Randomized Clinical Trial
(Brieflands, 2024-03-31) Mohammad Amin Heydarian; Atefeh Aminianfar; Fatemeh Paknazar
Introduction
No Thumbnail Available
Item
Survival of Patients with Right-Sided and Left-Sided Colon Cancer: Insights from an Iranian Medical Center
(Brieflands, 2024-02-29) Alimohammad Bananzadeh; Sara Shojaei-Zarghani; Amir Reza Bahadori; Ali Reza Safarpour
Objectives: We aimed to describe and compare the 12-year results of patients with colon cancer based on the Shiraz Colorectal Cancer Surgery (SCORCS) registry system in patients with a pathologically confirmed diagnosis of right-sided colon cancer (RCC) and left-sided colon cancer (LCC) who had undergone surgery. Methods: A total of 443 patients with a diagnosis of colon cancer at Shahid Faghihi Hospital, Shiraz, Iran, between 2010 and 2022, who were registered in the SCORCS system, were enrolled in the current study. The data collected included the patients' demographic characteristics, tumor site and size, degree of invasion, recurrence status, metastasis, and death. The data were analyzed using SPSS software version 21. Results: Among all patients, 61% underwent laparoscopy, 30% required conversion of laparoscopy to laparotomy, and the rest (9%) underwent laparotomy. The median follow-up time was 45 (range 25 - 87) months. RCC mostly occurred in men, while LCC predominantly affected women (P = 0.04). Overall survival (P = 0.45), recurrence (P = 0.85), and metastasis (P = 0.77) were similar between the RCC and LCC groups. In both groups, the tumor stage had a significant impact on the overall survival. Conclusions: Our long-term follow-up of patients indicates that overall survival, recurrence, and metastasis are similar between RCC and LCC. However, lymphatic, vascular, and perineural invasions were more common in RCC.
Thumbnail Image
Item
Comparing Analgesic Efficacy: Ropivacaine with Dexamethasone vs. Ropivacaine with Dexmedetomidine After Cesarean Section Using Transversus Abdominis Plane Block (2020 - 2021)
(Brieflands, 2024-10-31) Mohammadreza Jamshidi; Mona Ghaderi; Mitra Hojatansari
Background: There are several methods for managing postpartum pain. The combined use of drugs with anesthetics can lead to effective pain management. Objectives: The present study aimed to compare the analgesic effects of ropivacaine (RPV) + dexamethasone (DEXA) and RPV + dexmedetomidine (DEX) on pain after cesarean section (CS) using the transversus abdominis plane (TAP) block. Methods: This double-blind, randomized clinical trial employed a quadruple block randomization method and included 40 participants scheduled for CS at Ayatollah Mousavi Hospital in Zanjan, Iran, during 2020 - 2021. The participants were divided into two groups: The first group received 15 mL of RPV 2% combined with 100 µg of DEX via the bilateral TAP block method, while the second group received 15 ml of RPV 2% combined with 8 mg of DEXA. The analgesic effects of the two drug combinations were evaluated at 0, 3-, 6-, 12-, and 24-hours post-CS using the visual analog scale (VAS) to measure pain intensity. Data analysis was conducted using SPSS software, version 24. Results: In the RPV + DEX group, the onset of pain was delayed, resulting in a longer duration before the administration of painkillers (P = 0.041 and P < 0.001). However, pain intensity between 3- and 24-hours post-surgery was significantly higher in the RPV + DEX group compared to the RPV + DEXA group (P = 0.028, P < 0.001). The RPV + DEX group experienced longer durations before the onset of pain and the need for painkillers (P = 0.041, P < 0.001). Hypotension was more frequently observed in the RPV + DEXA group at 0 hours (P = 0.068) and 3 hours post-surgery (P = 0.003). Additionally, bradycardia and sedation incidences were higher in the RPV + DEXA group at 3 hours post-surgery (P = 0.005, P = 0.048). Conclusions: The use of RPV + DEXA, unlike RPV + DEX, demonstrated positive and significant effects on pain management in female CS candidates using the TAP block method, despite its side effects.